APO Research
Talk to an analyst

APO RESEARCH · REPORT

Eubiotics

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Eubiotics Market Outlook and Growth Opportunities 2026

26 December 2025197 pages

Choose your research edition.

Industry ResearchEubiotics Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Eubiotics Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Eubiotics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Eubiotics Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Eubiotics Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Eubiotics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Eubiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Eubiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Eubiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Eubiotics market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Eubiotics market include YARA International Asa, SCC Holdings Berhad, Royal DSM, Kemin Industries, DuPont, Chr. Hansen A/S, Cargill Incorporated, Beneo Group and Behn Meyer Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Eubiotics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Eubiotics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Eubiotics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Eubiotics market size, projected growth trends, production technologies, key applications, and end-use industries.

Eubiotics Segment by Company

YARA International Asa

SCC Holdings Berhad

Royal DSM

Kemin Industries

DuPont

Chr. Hansen A/S

Cargill Incorporated

Beneo Group

Behn Meyer Group

BASF SE

Eubiotics Segment by Type

Probiotics

Organic Acid

Eubiotics Segment by Application

Animals

Application 2

Eubiotics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Eubiotics status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Eubiotics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Eubiotics significant trends, drivers, influence factors in global and regions.

6. To analyze Eubiotics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Eubiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Eubiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Eubiotics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Eubiotics market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Eubiotics industry.

Chapter 3: Detailed analysis of Eubiotics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Eubiotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Eubiotics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Eubiotics Industry Trends Table 2. Eubiotics Industry Drivers Table 3. Eubiotics Industry Opportunities and Challenges Table 4. Eubiotics Industry Restraints Table 5. Global Eubiotics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Eubiotics Revenue Share by Company (2021-2026) Table 7. Global Eubiotics Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Eubiotics Sales Volume Share by Company (2021-2026) Table 9. Global Eubiotics Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Eubiotics Company Ranking, (2024-2026) & (USD Million) Table 11. Global Eubiotics Key Company Manufacturing Base & Headquarters Table 12. Global Eubiotics Company, Product Type & Application Table 13. Global Eubiotics Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Eubiotics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Probiotics Table 18. Significant Companies of Organic Acid Table 19. Global Eubiotics Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Eubiotics Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Eubiotics Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Eubiotics Sales Volume Share by Type (2021-2026) Table 23. Global Eubiotics Sales Volume Share by Type (2027-2032) Table 24. Global Eubiotics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Eubiotics Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Eubiotics Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Eubiotics Sales Value Share by Type (2021-2026) Table 28. Global Eubiotics Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Animals Table 30. Significant Companies of Application 2 Table 31. Global Eubiotics Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Eubiotics Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Eubiotics Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Eubiotics Sales Volume Share by Application (2021-2026) Table 35. Global Eubiotics Sales Volume Share by Application (2027-2032) Table 36. Global Eubiotics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Eubiotics Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Eubiotics Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Eubiotics Sales Value Share by Application (2021-2026) Table 40. Global Eubiotics Sales Value Share by Application (2027-2032) Table 41. Global Eubiotics Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Eubiotics Sales by Region (2021-2026) & (K Units) Table 43. Global Eubiotics Sales Market Share by Region (2021-2026) Table 44. Global Eubiotics Sales by Region (2027-2032) & (K Units) Table 45. Global Eubiotics Sales Market Share by Region (2027-2032) Table 46. Global Eubiotics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Eubiotics Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Eubiotics Sales Value Share by Region (2021-2026) Table 49. Global Eubiotics Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Eubiotics Sales Value Share by Region (2027-2032) Table 51. Global Eubiotics Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Eubiotics Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Eubiotics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Eubiotics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Eubiotics Sales by Country (2021-2026) & (K Units) Table 56. Global Eubiotics Sales Market Share by Country (2021-2026) Table 57. Global Eubiotics Sales by Country (2027-2032) & (K Units) Table 58. Global Eubiotics Sales Market Share by Country (2027-2032) Table 59. Global Eubiotics Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Eubiotics Sales Value Market Share by Country (2021-2026) Table 61. Global Eubiotics Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Eubiotics Sales Value Market Share by Country (2027-2032) Table 63. YARA International Asa Company Information Table 64. YARA International Asa Business Overview Table 65. YARA International Asa Eubiotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. YARA International Asa Eubiotics Product Portfolio Table 67. YARA International Asa Recent Development Table 68. SCC Holdings Berhad Company Information Table 69. SCC Holdings Berhad Business Overview Table 70. SCC Holdings Berhad Eubiotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. SCC Holdings Berhad Eubiotics Product Portfolio Table 72. SCC Holdings Berhad Recent Development Table 73. Royal DSM Company Information Table 74. Royal DSM Business Overview Table 75. Royal DSM Eubiotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Royal DSM Eubiotics Product Portfolio Table 77. Royal DSM Recent Development Table 78. Kemin Industries Company Information Table 79. Kemin Industries Business Overview Table 80. Kemin Industries Eubiotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Kemin Industries Eubiotics Product Portfolio Table 82. Kemin Industries Recent Development Table 83. DuPont Company Information Table 84. DuPont Business Overview Table 85. DuPont Eubiotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. DuPont Eubiotics Product Portfolio Table 87. DuPont Recent Development Table 88. Chr. Hansen A/S Company Information Table 89. Chr. Hansen A/S Business Overview Table 90. Chr. Hansen A/S Eubiotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Chr. Hansen A/S Eubiotics Product Portfolio Table 92. Chr. Hansen A/S Recent Development Table 93. Cargill Incorporated Company Information Table 94. Cargill Incorporated Business Overview Table 95. Cargill Incorporated Eubiotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Cargill Incorporated Eubiotics Product Portfolio Table 97. Cargill Incorporated Recent Development Table 98. Beneo Group Company Information Table 99. Beneo Group Business Overview Table 100. Beneo Group Eubiotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Beneo Group Eubiotics Product Portfolio Table 102. Beneo Group Recent Development Table 103. Behn Meyer Group Company Information Table 104. Behn Meyer Group Business Overview Table 105. Behn Meyer Group Eubiotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Behn Meyer Group Eubiotics Product Portfolio Table 107. Behn Meyer Group Recent Development Table 108. BASF SE Company Information Table 109. BASF SE Business Overview Table 110. BASF SE Eubiotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. BASF SE Eubiotics Product Portfolio Table 112. BASF SE Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Eubiotics Distributors List Table 116. Eubiotics Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Eubiotics Product Image Figure 2. Global Eubiotics Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Eubiotics Sales Value (2021-2032) & (US$ Million) Figure 4. Global Eubiotics Sales (2021-2032) & (K Units) Figure 5. Global Eubiotics Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Eubiotics Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Probiotics Image Figure 10. Organic Acid Image Figure 11. Global Eubiotics Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Eubiotics Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Eubiotics Sales Volume Share by Type (2021-2032) Figure 14. Global Eubiotics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Eubiotics Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Eubiotics Sales Value Share by Type (2021-2032) Figure 17. Animals Image Figure 18. Application 2 Image Figure 19. Global Eubiotics Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Eubiotics Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Eubiotics Sales Volume Share by Application (2021-2032) Figure 22. Global Eubiotics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Eubiotics Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Eubiotics Sales Value Share by Application (2021-2032) Figure 25. Global Eubiotics Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Eubiotics Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Eubiotics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Eubiotics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Eubiotics Sales Value (2021-2032) & (US$ Million) Figure 30. North America Eubiotics Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Eubiotics Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Eubiotics Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Eubiotics Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Eubiotics Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Eubiotics Sales Value (2021-2032) & (US$ Million) Figure 36. South America Eubiotics Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Eubiotics Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Eubiotics Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Eubiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Eubiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Eubiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Eubiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Eubiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Eubiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Eubiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Eubiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Eubiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Eubiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Eubiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Eubiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Eubiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Eubiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Eubiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Eubiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Eubiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Eubiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Eubiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Eubiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Eubiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Eubiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Eubiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Eubiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Eubiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Eubiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Eubiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Eubiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Eubiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Eubiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Eubiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Eubiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Eubiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Eubiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Eubiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Eubiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Eubiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Eubiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Eubiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Eubiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Eubiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Eubiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Eubiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Eubiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Eubiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Eubiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Eubiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Eubiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Eubiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Eubiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Eubiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Eubiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Eubiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Eubiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Eubiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Eubiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Eubiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Eubiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Eubiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Eubiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Eubiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Eubiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Eubiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Eubiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Eubiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Eubiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Eubiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Eubiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Eubiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Eubiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Eubiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Eubiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Eubiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Eubiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Eubiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Eubiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Eubiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Eubiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Eubiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Eubiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Eubiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Eubiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Eubiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Eubiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Eubiotics Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Eubiotics Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Probiotics
  • Organic Acid
Applications
  • Animals
  • Application 2
Companies covered
  • YARA International Asa
  • SCC Holdings Berhad
  • Royal DSM
  • Kemin Industries
  • DuPont
  • Chr. Hansen A/S
  • Cargill Incorporated
  • Beneo Group
  • Behn Meyer Group
  • BASF SE

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Eubiotics Sales Value (2021-2032)
  4. 1.2.2 Global Eubiotics Sales Volume (2021-2032)
  5. 1.2.3 Global Eubiotics Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Eubiotics Market Dynamics
  1. 2.1 Eubiotics Industry Trends
  2. 2.2 Eubiotics Industry Drivers
  3. 2.3 Eubiotics Industry Opportunities and Challenges
  4. 2.4 Eubiotics Industry Restraints
3 Eubiotics Market by Company
  1. 3.1 Global Eubiotics Company Revenue Ranking in 2025
  2. 3.2 Global Eubiotics Revenue by Company (2021-2026)
  3. 3.3 Global Eubiotics Sales Volume by Company (2021-2026)
  4. 3.4 Global Eubiotics Average Price by Company (2021-2026)
  5. 3.5 Global Eubiotics Company Ranking (2024-2026)
  6. 3.6 Global Eubiotics Company Manufacturing Base and Headquarters
  7. 3.7 Global Eubiotics Company Product Type and Application
  8. 3.8 Global Eubiotics Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Eubiotics Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Eubiotics Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Eubiotics Market by Type
  1. 4.1 Eubiotics Type Introduction
  2. 4.1.1 Probiotics
  3. 4.1.2 Organic Acid
  4. 4.2 Global Eubiotics Sales Volume by Type
  5. 4.2.1 Global Eubiotics Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Eubiotics Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Eubiotics Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Eubiotics Sales Value by Type
  9. 4.3.1 Global Eubiotics Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Eubiotics Sales Value by Type (2021-2032)
  11. 4.3.3 Global Eubiotics Sales Value Share by Type (2021-2032)
5 Eubiotics Market by Application
  1. 5.1 Eubiotics Application Introduction
  2. 5.1.1 Animals
  3. 5.1.2 Application 2
  4. 5.2 Global Eubiotics Sales Volume by Application
  5. 5.2.1 Global Eubiotics Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Eubiotics Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Eubiotics Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Eubiotics Sales Value by Application
  9. 5.3.1 Global Eubiotics Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Eubiotics Sales Value by Application (2021-2032)
  11. 5.3.3 Global Eubiotics Sales Value Share by Application (2021-2032)
6 Eubiotics Regional Sales and Value Analysis
  1. 6.1 Global Eubiotics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Eubiotics Sales by Region (2021-2032)
  3. 6.2.1 Global Eubiotics Sales by Region: 2021-2026
  4. 6.2.2 Global Eubiotics Sales by Region (2027-2032)
  5. 6.3 Global Eubiotics Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Eubiotics Sales Value by Region (2021-2032)
  7. 6.4.1 Global Eubiotics Sales Value by Region: 2021-2026
  8. 6.4.2 Global Eubiotics Sales Value by Region (2027-2032)
  9. 6.5 Global Eubiotics Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Eubiotics Sales Value (2021-2032)
  12. 6.6.2 North America Eubiotics Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Eubiotics Sales Value (2021-2032)
  15. 6.7.2 Europe Eubiotics Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Eubiotics Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Eubiotics Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Eubiotics Sales Value (2021-2032)
  21. 6.9.2 South America Eubiotics Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Eubiotics Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Eubiotics Sales Value Share by Country, 2025 VS 2032
7 Eubiotics Country-level Sales and Value Analysis
  1. 7.1 Global Eubiotics Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Eubiotics Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Eubiotics Sales by Country (2021-2032)
  4. 7.3.1 Global Eubiotics Sales by Country (2021-2026)
  5. 7.3.2 Global Eubiotics Sales by Country (2027-2032)
  6. 7.4 Global Eubiotics Sales Value by Country (2021-2032)
  7. 7.4.1 Global Eubiotics Sales Value by Country (2021-2026)
  8. 7.4.2 Global Eubiotics Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Eubiotics Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Eubiotics Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Eubiotics Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Eubiotics Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Eubiotics Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Eubiotics Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Eubiotics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Eubiotics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Eubiotics Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Eubiotics Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Eubiotics Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Eubiotics Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Eubiotics Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Eubiotics Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Eubiotics Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Eubiotics Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Eubiotics Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Eubiotics Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Eubiotics Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Eubiotics Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Eubiotics Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Eubiotics Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Eubiotics Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Eubiotics Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Eubiotics Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Eubiotics Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Eubiotics Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Eubiotics Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Eubiotics Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Eubiotics Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Eubiotics Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Eubiotics Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Eubiotics Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Eubiotics Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Eubiotics Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Eubiotics Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Eubiotics Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Eubiotics Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Eubiotics Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Eubiotics Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Eubiotics Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Eubiotics Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Eubiotics Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Eubiotics Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Eubiotics Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Eubiotics Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Eubiotics Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Eubiotics Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Eubiotics Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Eubiotics Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Eubiotics Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Eubiotics Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Eubiotics Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Eubiotics Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Eubiotics Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Eubiotics Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Eubiotics Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Eubiotics Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Eubiotics Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Eubiotics Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Eubiotics Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Eubiotics Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Eubiotics Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Eubiotics Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Eubiotics Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Eubiotics Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Eubiotics Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Eubiotics Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Eubiotics Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Eubiotics Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Eubiotics Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Eubiotics Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Eubiotics Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Eubiotics Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Eubiotics Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Eubiotics Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Eubiotics Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Eubiotics Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Eubiotics Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Eubiotics Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Eubiotics Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Eubiotics Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Eubiotics Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Eubiotics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 YARA International Asa
  2. 8.1.1 YARA International Asa Company Information
  3. 8.1.2 YARA International Asa Business Overview
  4. 8.1.3 YARA International Asa Eubiotics Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 YARA International Asa Eubiotics Product Portfolio
  6. 8.1.5 YARA International Asa Recent Developments
  7. 8.2 SCC Holdings Berhad
  8. 8.2.1 SCC Holdings Berhad Company Information
  9. 8.2.2 SCC Holdings Berhad Business Overview
  10. 8.2.3 SCC Holdings Berhad Eubiotics Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 SCC Holdings Berhad Eubiotics Product Portfolio
  12. 8.2.5 SCC Holdings Berhad Recent Developments
  13. 8.3 Royal DSM
  14. 8.3.1 Royal DSM Company Information
  15. 8.3.2 Royal DSM Business Overview
  16. 8.3.3 Royal DSM Eubiotics Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Royal DSM Eubiotics Product Portfolio
  18. 8.3.5 Royal DSM Recent Developments
  19. 8.4 Kemin Industries
  20. 8.4.1 Kemin Industries Company Information
  21. 8.4.2 Kemin Industries Business Overview
  22. 8.4.3 Kemin Industries Eubiotics Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Kemin Industries Eubiotics Product Portfolio
  24. 8.4.5 Kemin Industries Recent Developments
  25. 8.5 DuPont
  26. 8.5.1 DuPont Company Information
  27. 8.5.2 DuPont Business Overview
  28. 8.5.3 DuPont Eubiotics Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 DuPont Eubiotics Product Portfolio
  30. 8.5.5 DuPont Recent Developments
  31. 8.6 Chr. Hansen A/S
  32. 8.6.1 Chr. Hansen A/S Company Information
  33. 8.6.2 Chr. Hansen A/S Business Overview
  34. 8.6.3 Chr. Hansen A/S Eubiotics Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Chr. Hansen A/S Eubiotics Product Portfolio
  36. 8.6.5 Chr. Hansen A/S Recent Developments
  37. 8.7 Cargill Incorporated
  38. 8.7.1 Cargill Incorporated Company Information
  39. 8.7.2 Cargill Incorporated Business Overview
  40. 8.7.3 Cargill Incorporated Eubiotics Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Cargill Incorporated Eubiotics Product Portfolio
  42. 8.7.5 Cargill Incorporated Recent Developments
  43. 8.8 Beneo Group
  44. 8.8.1 Beneo Group Company Information
  45. 8.8.2 Beneo Group Business Overview
  46. 8.8.3 Beneo Group Eubiotics Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Beneo Group Eubiotics Product Portfolio
  48. 8.8.5 Beneo Group Recent Developments
  49. 8.9 Behn Meyer Group
  50. 8.9.1 Behn Meyer Group Company Information
  51. 8.9.2 Behn Meyer Group Business Overview
  52. 8.9.3 Behn Meyer Group Eubiotics Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Behn Meyer Group Eubiotics Product Portfolio
  54. 8.9.5 Behn Meyer Group Recent Developments
  55. 8.10 BASF SE
  56. 8.10.1 BASF SE Company Information
  57. 8.10.2 BASF SE Business Overview
  58. 8.10.3 BASF SE Eubiotics Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 BASF SE Eubiotics Product Portfolio
  60. 8.10.5 BASF SE Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Eubiotics Value Chain Analysis
  2. 9.1.1 Eubiotics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Eubiotics Sales Mode & Process
  6. 9.2 Eubiotics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Eubiotics Distributors
  9. 9.2.3 Eubiotics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst